Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28594934
Publication Date : //

Effects of PPARα inhibition in head and neck paraganglioma cells.


Head and neck paragangliomas (HNPGLs) are rare tumors that may cause important morbidity, because of their tendency to infiltrate the skull base. At present, surgery is the only therapeutic option, but radical removal may be difficult or impossible. Thus, effective targets and molecules for HNPGL treatment need to be identified. However, the lack of cellular models for this rare tumor hampers this task. PPARα receptor activation was reported in several tumors and this receptor appears to be a promising therapeutic target in different malignancies. Considering that the role of PPARα in HNPGLs was never studied before, we analyzed the potential of modulating PPARα in a unique model of HNPGL cells. We observed an intense immunoreactivity for PPARα in HNPGL tumors, suggesting that this receptor has an important role in HNPGL. A pronounced nuclear expression of PPARα was also confirmed in HNPGL-derived cells. The specific PPARα agonist WY14643 had no effect on HNPGL cell viability, whereas the specific PPARα antagonist GW6471 reduced HNPGL cell viability and growth by inducing cell cycle arrest and caspase-dependent apoptosis. GW6471 treatment was associated with a marked decrease of CDK4, cyclin D3 and cyclin B1 protein expression, along with an increased expression of p21 in HNPGL cells. Moreover, GW6471 drastically impaired clonogenic activity of HNPGL cells, with a less marked effect on cell migration. Notably, the effects of GW6471 on HNPGL cells were associated with the inhibition of the PI3K/GSK3β/β-catenin signaling pathway. In conclusion, the PPARα antagonist GW6471 reduces HNPGL cell viability, interfering with cell cycle and inducing apoptosis. The mechanisms affecting HNPGL cell viability involve repression of the PI3K/GSK3β/β-catenin pathway. Therefore, PPARα could represent a novel therapeutic target for HNPGL.

Authors : Florio Rosalba , De Lellis Laura , di Giacomo Viviana , Di Marcantonio Maria Carmela , Cristiano Loredana , Basile Mariangela , Verginelli Fabio , Verzilli Delfina , Ammazzalorso Alessandra , Prasad Sampath Chandra , Cataldi Amelia , Sanna Mario , Cimini Annamaria , Mariani-Costantini Renato , Mincione Gabriella , Cama Alessandro ,

Related products :

Catalog number Product name Quantity
Head&Neck - HND181 Head and neck disease tissue array, 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and salivary glands 2.5mm
Head&Neck - HNT961 Head and neck disease tissue array, 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynx, larynx and salivary glands 1.5 mm
HND181 Head and neck disease tissue array, 18 cases (2.5mm) Species Human Anatomic System Head and neck 2.5 mm
HNT1021 Head and neck tumor tissue array, 102 cases (1.5mm) Species Human Anatomic System Head and neck 1.5 mm
HNT961 Head and neck tumor tissue array, 48 cases, 96 samples (1.5mm) Species Human Anatomic System Head and neck 1.5 mm
1744 Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN241
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing HN241; ihc Anti-Actin confirmed
Z7020050 Head & Neck Tumor Tissue Array - 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and sali
Z7020051 Head & Neck Tumor Tissue Array _ 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharyn 5 slides
Z7020051 Head & Neck Tumor Tissue Array - 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharyn 5 slides
Z7020050 Head & Neck Tumor Tissue Array - 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and sali 5 slides
Z7020050 Head & Neck Tumor Tissue Array _ 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and sali 5 slides
Z7020051 Head & Neck Tumor Tissue Array - 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharyn
Z7020051 Head & Neck Tumor Tissue Array _ 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharyn 5 slides
Z7020050 Head & Neck Tumor Tissue Array _ 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and sali 5 slides
HNT1021 Head and neck 102 Cases
HNT961 Head and neck 48 Cases
HNT962 Head and neck 48 Cases
HND181 Head and neck 18 Cases
KMA026 Model of head and neck Set
IHDNK-N-1ml Head and Neck Carcinoma Plasma 1ml 1ml
IHDNK-SER-1ml Head and Neck Carcinoma Serum 1ml 1ml
KMA026 Model of head and neck, 220x230x340 5x
IHDNK-SER-Each Head and Neck Carcinoma Serum Each
IHDNK-N-Each Head and Neck Carcinoma Plasma Each


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur